ArticlePloS one2019

Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.

Patricia van den Hoogen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.